Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06564207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

Study acronym: FOSTA-ARDS
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: May 31, 2026 to May 31, 2027
    • Start date: Nov 30, 2025 to Aug 30, 2026
    • Study completion date: Oct 31, 2026 to Oct 31, 2027
    v9
  2. Start date: Jul 31, 2025 to Nov 30, 2025v8
  3. Start date: May 1, 2025 to Jul 31, 2025v7
  4. Primary completion date: Aug 31, 2025 to May 31, 2026
    • Start date: Feb 1, 2025 to May 1, 2025
    • Study completion date: Oct 31, 2025 to Oct 31, 2026
    v6
  5. Start date: Jan 1, 2025 to Feb 1, 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Nov 1, 2024 to Jan 1, 2025v4
  2. Start date: Aug 30, 2024 to Nov 1, 2024v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is designed to evaluate the safety and efficacy of fostamatinib in hospitalized adult participants with acute respiratory distress syndrome (ARDS).
Trial Details
NCT Number NCT06564207
Lead Sponsor Inova Health Care Services
Collaborators: Rigel Pharmaceuticals, Biomedical Advanced Research and Development Authority
Conditions
(from sponsor)		 Acute Respiratory Distress Syndrome, ARDS
Related terms Respiratory Distress Syndrome
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov